Covered recipient · General Payments record
OMAR FARHAT
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2021–2024
$1,832.39
- Reported across 25 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $717.18 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GLAUKOS CORPORATION | $259.17 | 3 |
| Alcon Laboratories Inc | $186.29 | 4 |
| Amgen Inc. | $124.99 | 1 |
| Merz Pharmaceuticals, LLC | $99.15 | 1 |
| Oyster Point Pharma, Inc. | $47.58 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alcon Vision LLC | $2.63 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110710429 | CMS |
| Alcon Vision LLC | $21.53 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110710431 | CMS |
| Alcon Vision LLC | $34.81 | 07/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110710433 | CMS |
| Alcon Vision LLC | $127.32 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110710435 | CMS |
| Amgen Inc. | $124.99 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115614850 | CMS |
| Glaukos Corporation | $108.56 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151983166 | CMS |
| Glaukos Corporation | $132.77 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151983168 | CMS |
| Glaukos Corporation | $17.84 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151983164 | CMS |
| Merz Pharmaceuticals, LLC | $99.15 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137953310 | CMS |
| Oyster Point Pharma, Inc. | $21.61 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147412732 | CMS |
| Oyster Point Pharma, Inc. | $25.97 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147416152 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.